0000000000308056

AUTHOR

J Spencer

JA47, a new histone deacetylase inhibitor that induces cytotoxic effects on triple-negative MDA-MB231 breast cancer cells in vitro

research product

Gene and protein signatures associated to treatment of MDA-MB231 breast cancer cells with JAHA, a novel histone deacetylase inhibitor

research product

Biological effect of an hybrid anticancer agent based on kinase and histone deacetylase inhibitor on breast cancer cells

research product

The effect of the HDACi JAHA on DNA methylation of breast cancer cells by down-regulating DNMT1 through ERK signaling

research product

JAHA, a novel histone deacetylase inhibitor: cytotoxic effect on triple-negative breast cancer cells

research product

Cytotoxic effects induced by JA47, a novel histone deacetylase inhibitor (HDACi), on MDA-MB231 breast cancer cells

research product